sars cov 2 impfstoff

Coronavirus disease (COVID-19): Vaccines and vaccine safety

World Health Organization (WHO) - 05 Dec 2023
Coronavirus disease (COVID-19): Vaccines and vaccine safety ...

Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection

Nature.com - 26 Feb 2024
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection ...

Safe COVID-19 vaccines for Europeans - Europäische Kommission

European Union - 25 Aug 2023
Safe COVID-19 vaccines for Europeans - Europäische Kommission ...

Further developed COVID vaccine from MedUni Vienna shows promising results against Omikron

MedUni Wien - 11 Mar 2024
Further developed COVID vaccine from MedUni Vienna shows promising results against Omikron ...

JN1 als Basis für angepasste Covid-19-Impfstoffe

Pharmazeutische Zeitung - 29 Apr 2024
JN1 als Basis für angepasste Covid-19-Impfstoffe ...

Coronavirus (COVID-19) Vaccinations

Our World in Data - 16 Dec 2020
Coronavirus (COVID-19) Vaccinations ...

More Than 12.7 Billion Shots Given: Covid-19 Tracker

Bloomberg - 06 Oct 2022
More Than 12.7 Billion Shots Given: Covid-19 Tracker ...

The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know

World Health Organization (WHO) - 18 Aug 2022
The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know ...

What are the ingredients of Pfizer’s covid-19 vaccine?

MIT Technology Review - 09 Dec 2020
What are the ingredients of Pfizer’s covid-19 vaccine? ...

NIH clinical trial of investigational vaccine for COVID-19 begins

National Institutes of Health (NIH) (.gov) - 16 Mar 2020
NIH clinical trial of investigational vaccine for COVID-19 begins ...

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM

nejm.org - 25 Aug 2021
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM ...

Trial of Oxford COVID-19 vaccine in South Africa begins

University of Oxford - 23 Jun 2020
Trial of Oxford COVID-19 vaccine in South Africa begins ...

SARS-CoV-2 vaccines in development

Nature.com - 23 Sep 2020
SARS-CoV-2 vaccines in development ...

The Novavax vaccine against COVID-19: What you need to know

World Health Organization (WHO) - 28 Sep 2022
The Novavax vaccine against COVID-19: What you need to know ...

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM

nejm.org - 13 Jan 2021
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM ...

Experimental coronavirus vaccine highly effective

National Institutes of Health (NIH) (.gov) - 12 Jan 2021
Experimental coronavirus vaccine highly effective ...

Oxford COVID-19 vaccine to begin phase II/III human trials

University of Oxford - 22 May 2020
Oxford COVID-19 vaccine to begin phase II/III human trials ...

Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine

Nature.com - 04 Jul 2022
Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine ...

Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine

World Health Organization (WHO) - 03 Jun 2022
Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine ...